EVIDENCE LIBRARY
Naringenin Experiment Combined Diazepam With Thiopental-Induced Sleep in Mice
A mouse study found that naringenin altered induced sleep and interacted with diazepam. Its laboratory and docking findings did not establish a human insomnia treatment.
A mouse study found that naringenin altered induced sleep and interacted with diazepam. Its laboratory and docking findings did not establish a human insomnia treatment.
The actual model
The experiment administered naringenin, diazepam, flumazenil, or combinations before thiopental-induced sleep. Naringenin shortened latency and prolonged duration, while flumazenil attenuated the reported effect.
The authors described an enhanced combined effect with diazepam and docking compatible with a GABA-related hypothesis. These are different kinds of evidence: animal behavior and computational predictions.
Clinical boundaries
Thiopental-induced loss of righting is not ordinary human sleep architecture or insomnia remission. Intraperitoneal dosing also differs from dietary exposure or a commercial supplement. An enhanced combination response does not establish a safe human interaction or formal clinical synergy.
Docking scores do not measure receptor occupancy in a patient. Likewise, a high acute-toxicity threshold does not establish repeated-use safety, dependence risk, or next-day driving performance. The paper supports further mechanistic work rather than substituting a flavonoid for a prescribed sedative.
Source paper
Original analysis of the supplied journal article, identified as PMC12518047.